Citadel Advisors’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-5,213
| Closed | -$50K | – | 5352 |
|
|
2019
Q2 | $50K | Sell |
5,213
-69
| -1% | -$662 | ﹤0.01% | 4357 |
|
|
2019
Q1 | $142K | Sell |
5,282
-723
| -12% | -$19.4K | ﹤0.01% | 4034 |
|
|
2018
Q4 | $136K | Sell |
6,005
-2,937
| -33% | -$66.5K | ﹤0.01% | 3950 |
|
|
2018
Q3 | $494K | Sell |
8,942
-379
| -4% | -$20.9K | ﹤0.01% | 3174 |
|
|
2018
Q2 | $666K | Buy |
9,321
+6,772
| +266% | +$484K | ﹤0.01% | 2956 |
|
|
2018
Q1 | $157K | Buy |
2,549
+1,191
| +88% | +$73.4K | ﹤0.01% | 3546 |
|
|
2017
Q4 | $171K | Buy |
+1,358
| New | +$171K | ﹤0.01% | 3428 |
|
|
2017
Q2 | – | Sell |
-796
| Closed | -$146K | – | 4381 |
|
|
2017
Q1 | $146K | Buy |
796
+125
| +19% | +$22.9K | ﹤0.01% | 3267 |
|
|
2016
Q4 | $54K | Sell |
671
-609
| -48% | -$49K | ﹤0.01% | 3307 |
|
|
2016
Q3 | $98K | Buy |
+1,280
| New | +$98K | ﹤0.01% | 3202 |
|
|
2016
Q2 | – | Sell |
-2,189
| Closed | -$203K | – | 4125 |
|
|
2016
Q1 | $203K | Buy |
2,189
+698
| +47% | +$64.7K | ﹤0.01% | 2712 |
|
|
2015
Q4 | $299K | Sell |
1,491
-1,046
| -41% | -$210K | ﹤0.01% | 2712 |
|
|
2015
Q3 | $379K | Sell |
2,537
-16,619
| -87% | -$2.48M | ﹤0.01% | 2786 |
|
|
2015
Q2 | $18.2M | Buy |
19,156
+1,578
| +9% | +$1.5M | 0.02% | 735 |
|
|
2015
Q1 | $12.9M | Buy |
17,578
+17,562
| +109,763% | +$12.9M | 0.01% | 864 |
|
|
2014
Q4 | $12K | Buy |
+16
| New | +$12K | ﹤0.01% | 3744 |
|
|
2014
Q2 | – | Sell |
-996
| Closed | -$217K | – | 3860 |
|
|
2014
Q1 | $217K | Buy |
+996
| New | +$217K | ﹤0.01% | 2800 |
|